Navigation Links
Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting
Date:4/23/2009

ALISO VIEJO, Calif., April 23 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX) today announced that results from the week-60 analysis for its Phase IIb dose-finding clinical trial for taribavirin, a prodrug of ribavirin which is in development for the treatment of chronic hepatitis C in conjunction with a pegylated interferon, was presented today at the European Association for the Study of Liver (EASL) 44th Annual Meeting in Copenhagen, Denmark.

The results were presented in an abstract entitled "Efficacy And Safety of Weight-Based Regimens of Taribavirin or Ribavirin, Given With Peginterferon Alfa-2b, At 12 Weeks After Treatment (SVR12) In Naive Patients With Genotype 1 Chronic-Hepatitis C", with an oral presentation given by Fred Poordad, M.D., Chief of Hepatology at the Center for Liver Disease and Transplant, Cedars-Sinai Medical Center, Los Angeles, CA and principal investigator in this study.

The company previously reported week 12 and 48 results from this Phase IIb trial. The study consists of 48 weeks of treatment with a 24-week post-treatment follow-up period during which period the week 60 results were collected from the arms receiving 20mg/kg and 25mg/kg taribavirin and the ribavirin control arm. Similar to the week 12 and 48 results, the 60-week viral response data continue to show comparable reductions in viral load for weight-based doses of taribavirin and ribavirin in a difficult-to-treat population of subjects infected Hepatitis C genotype 1. At the end of week 60, the statistically significantly lower anemia rate for patients receiving taribavirin in the 20mg/kg and 25mg/kg arms versus the ribavirin control arm has been maintained at a rate similar to the end of treatment (week 48).

    Table:  Efficacy/Safety (intent-to-treat)

                                          Phas
'/>"/>
SOURCE Valeant Pharmaceuticals International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Valeant Pharmaceuticals to Announce 2009 First Quarter Results on May 5, 2009
2. Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International
3. Valeant Pharmaceuticals to Present at Cowen and Company 29th Annual Health Care Conference
4. Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date
5. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
6. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
7. Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
8. Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM)
9. Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name
10. Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
11. Genesis Pharmaceuticals Announces the Launch of Three TCM Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 Nutritional ... and actually prevent a variety of health conditions and ... this modern research to adopt clean eating methods to ... artificial dyes associated with over-consumption of fast and processed ... plans easy to follow and report feeling better ...
(Date:5/5/2015)... MAP Health Management, LLC, a provider of ... addiction treatment facilities, announced today that Jimmy Mooney has ... Mr. Mooney, who has more than 35 years of ... for developing new strategic partnerships with substance abuse facilities ... new initiatives. , Prior to joining MAP, Mr. Mooney ...
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... Amplify Hope Initiative, a new study aimed at determining ... disease patients. RG is an international non-profit providing rare ... genomics sequencing technology, connections to scientists and researchers, and ... or crowdfunding. , “I am excited to see how ...
(Date:5/5/2015)... May 05, 2015 For the growing list ... series of data loggers. This data logger series ... electronic components for optimum performance throughout exposure to high temperatures ... loggers are capable of storing up to 32,700 readings ... life of one year or longer. All data loggers in ...
(Date:5/5/2015)... 2015 Sheltering Arms held its annual ... Frazier and Cravath, Swaine & Moore LLP for their ... The event was co-chaired by Vanguard sponsors Morgan Stanley ... Chapter” highlighted Sheltering Arms’ significant growth in New York ... February 2015. Formerly Episcopal Social Services, Sheltering Arms has ...
Breaking Medicine News(10 mins):Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 3Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 4Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 5Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 6Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2
... Hanger Orthopedic,Group, Inc. (NYSE: HGR ) announces ... 30, 2008, an increase of $16.4 million, or 10.1%,from ... income for,the quarter was $7.3 million, an increase of ... year. Diluted earnings per share for the,third quarter 2008 ...
... later, studies find , , MONDAY, Oct. 27 (HealthDay News) ... the risk of a heart attack, and those who ... heart-related complications, new research says. , It seems ... lower chambers of the heart to become stiff, is ...
... the growing number who choose later-in-life pregnancy, predicting their ... and infertility is critically important. , Now, investigators ... about hormonal biomarkers that can address the beginning ... this information can change the way we do business," ...
... The HealthCentral,Network, Inc. (http://www.HealthCentral.com ) announced today ... for HealthCentral, has been,named President and Chief Operating ... track record of growing young businesses, Shane will,oversee ... for,audience growth, user engagement, and revenue, and will ...
... Web-based project educates and empowers through personal stories of,North ... N.C., Oct. 27 Eighty percent of,women living with ... leading cause of death for African American women ages ... and Test for Life,will host a demonstration and discussion ...
... AARP, one of the world,s,largest member organizations with ... people 50+, today announced that renown journalist and ... been named Ambassador,of Caregiving for the organization. In ... members through the emotional and practical sides of,the ...
Cached Medicine News:Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 9Health News:Rheumatoid Arthritis a Threat to the Heart 2Health News:Rheumatoid Arthritis a Threat to the Heart 3Health News:Rheumatoid Arthritis a Threat to the Heart 4Health News:New hormone data can predict menopause within a year 2Health News:The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer 2Health News:The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer 3Health News:Southern AIDS Living Quilt Project in Raleigh Tomorrow 2Health News:Gail Sheehy Named AARP's Ambassador of Caregiving 2Health News:Gail Sheehy Named AARP's Ambassador of Caregiving 3
(Date:5/5/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) today ... 31, 2015 and reaffirmed its revenue, non-GAAP EBITDA, and ... First Quarter 2015 Highlights Include: , First quarter ... compared to $10.9 million for the same period in ... $11.5 million, an increase of 170% as compared to $4.2 ...
(Date:5/5/2015)...  InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading ... the U.S. healthcare industry, today announced that it will ... 2015 after the market closes. The Company ... Tuesday, May 12, 2015 at 4:30 p.m. Eastern Time ... in this call, please dial in toll-free 1-800-446-1671 and ...
(Date:5/5/2015)... 5, 2015 The National Association of ... of its 6 th Annual Most Influential ... CEO of Ear Professionals International Corporation (dba EPIC ... in the nation, EPIC Hearing Service Plans cover ... care organizations, employers, health plans, unions and through ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 2ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 3ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 4ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 5ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 6ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 7ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 8ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 9EPIC Hearing Healthcare CEO Brad Volkmer Awarded 6th Annual Most Influential In Specialty Health 2
... Oct. 5, 2011 In an independent study published ... University of Texas Health Science Center San Antonio have ... compromised blood flow during reconstructive microsurgery when compared clinically ... by Dr. Cornejo and colleagues is important as compromised ...
... "Superheroes of Nursing" shows appreciation to nurses; contest ... four-month period Elsevier , a world-leading ... services, announced today the winners of the Mosby,s Nursing ... to search and identify the real-life superheroes in the ...
Cached Medicine Technology:Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery 2Real Superheroes of Nursing, from Mosby's Nursing, Announced at 13th Annual ANCC Magnet Conference 2Real Superheroes of Nursing, from Mosby's Nursing, Announced at 13th Annual ANCC Magnet Conference 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: